Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,769 total articles

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Palvella Therapeutics announced two poster presentations at the 2026 American Academy of Dermatology Annual Meeting highlighting advances in their rare skin disease pipeline. Key data include the innovative QTORIN™ rapamycin anhydrous gel formulation overcoming prior drug stability issues and positive Phase 3 results in microcystic lymphatic malfor…

XORTX Announces Results of  Annual and Special Meeting of Shareholders

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Therapeutics Inc. announced the results of its annual and special shareholders meeting held on March 24, 2026. Key approvals included election of all five board nominees, appointment of auditors, re-approval of the stock option plan, and authorization of share consolidation. The company focuses on developing treatments for gout and progressiv…

STMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of Shareholders

STMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of Shareholders

STMicroelectronics has detailed the resolutions for its 2026 Annual General Meeting, including approval of the 2025 financial accounts, distribution of quarterly dividends, reappointment of board members, and authorizations for share repurchases and issuances. The company also highlighted its sustainability commitments and compliance with regulator…

Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share

Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share

Datacentrex, Inc., a digital infrastructure company operating Scrypt compute assets, has priced a confidentially marketed public offering of common stock and pre-funded warrants at $2.00 per share, expecting gross proceeds of approximately $20.17 million. The offering will close around March 30, 2026, with net proceeds intended for working capital …

YPF SA reports

YPF SA reports

YPF SA, Argentina's largest energy company, has filed its annual Form 20-F for the fiscal year ended December 31, 2025, with the US Securities and Exchange Commission, including audited financial statements. The report is accessible on YPF's official website and the SEC website. As a major producer of oil and natural gas in Argentina, with signific…

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies, a late-stage biopharmaceutical company focused on food allergy treatments, announced the filing of its 2025 Annual Report on Form 10-K with the U.S. SEC and the Universal Registration Document with the French market authority. The filings include comprehensive financial data, corporate governance reports, share buy-back informatio…

Rumble Announces Chief Financial Officer Transition

Rumble Announces Chief Financial Officer Transition

Rumble Inc., a Nasdaq-listed technology platform company, announced the appointment of Mike Masci as its new Chief Financial Officer effective March 31, 2026. Masci brings extensive experience from Intel in AI, cloud infrastructure, and financial leadership, positioning Rumble for growth as it scales its platform and pursues AI infrastructure oppor…

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Incorporated reported a profitable fourth quarter for 2025, achieving net income of $0.9 million compared to a loss in the prior year quarter. The company saw increased net sales to $30.3 million and significant improvement in EBITDA, reflecting successful strategic restructuring and operational efficiencies. Nortech also secured $1…

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. has expanded its Board of Directors to include Jeff Evans, who brings over 30 years of experience in property management, construction, and real estate. Evans is also nominated for reelection at the upcoming Annual Meeting of Shareholders. The company and its subsidiary, AuburnBank, operate primarily in East Ala…

Fortuna files Form 40-F, Annual Report

Fortuna files Form 40-F, Annual Report

Fortuna Mining Corp., a Canadian precious metals mining company, has filed its annual report on Form 40-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements, management's discussion and analysis, and an annual information form. The company oper…

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on therapies for gout and progressive kidney disease, announced a delay in the effective date of its 1-for-5 share consolidation from March 27, 2026, to April 6, 2026. The consolidation remains subject to necessary approvals from the TSX Venture Exchange and Nasdaq Stock …

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group, Inc. announced its 2026 Annual Meeting of Stockholders to be held on May 14, 2026, and provided an update on its annual filings. The company disclosed that its audited financial statements for fiscal year 2025 included a going concern qualification from its independent auditor, highlighting uncertainties regarding its a…

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Disc Medicine has completed enrollment of the Phase 3 APOLLO trial for bitopertin, an investigational oral treatment for erythropoietic protoporphyria (EPP). The study was expanded from 150 to 183 participants due to high demand. Results are expected in Q4 2026, with subsequent regulatory engagement aimed at FDA approval potentially by mid-2027. Th…

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

CVB Financial Corp. and Heritage Commerce Corp. announced shareholder approval for their proposed merger. The transaction, pending regulatory approvals, is expected to close in the second quarter of 2026. The merger aims to combine two strong California-based banking organizations to enhance service offerings and achieve operational synergies.

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical, a clinical-stage biopharmaceutical company, announced positive results from their first-in-human LIBERATE-1 study and preclinical data for their semaglutide implant (NPM-139), demonstrating sustained drug exposure and over 20% weight loss for one year. The company plans to initiate a Phase 1 clinical study in mid-2026 with anticipat…

AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

AmpliTech Group reported a stellar fiscal year 2025 with revenue reaching $25.2 million, marking a 165% increase from the prior year, driven by strong demand for its 5G-related low noise amplifier and block products. The company strategically invested in expanding its 5G product lines and penetration into Tier 1 network operators despite gross marg…